MIN's 83c bid conditional on "the independent expert concluding that the Scheme is in the best interests of AWE shareholders". Counter-bid from CERCG would test the AWE Board. DYOR
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025